Efficacy of ensitrelvir for cough due to COVID-19 Omicron variant in medical healthcare workers.
Antimicrob Agents Chemother
; 68(10): e0106424, 2024 Oct 08.
Article
em En
| MEDLINE
| ID: mdl-39207153
ABSTRACT
We evaluated the efficacy of ensitrelvir for the treatment of cough due to coronavirus disease 2019 Omicron variant in medical healthcare workers. A total of 633 patients were registered in this study 206 patients chose ensitrelvir and 427 patients chose symptomatic treatment. Difference in score changes using the Leicester Cough Questionnaire between groups was 3.17 on day 4, 3.24 on day 7, and 2.46 on day 14. The analysis demonstrated a significant difference at all time points.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pessoal de Saúde
/
Tosse
/
SARS-CoV-2
/
COVID-19
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article